WASHINGTON, Nov. 17 /Xinhua-PRNewswire/ -- The Biotechnology Industry
Organization (BIO) will host its fourth annual BIO-Asia Partnering Conference
in Tokyo at the Grand Hyatt Tokyo, Jan. 29-30, 2007.
Koichiro Aramaki, Ph.D., Chairman & Chief Executive Officer, Kirin
Brewery Co., Ltd., will deliver the luncheon keynote address at noon Monday,
Jan. 29, 2007. Tuesday’s luncheon keynote will be delivered by Anthony
Rosenberg, Head of Global Business Development & Licensing, Novartis Pharma
AG.
BIO-Asia 2007 is an exclusive partnering forum, which brings together
Asian, U.S., Australian and European biotechnology and pharmaceutical
companies interested in research collaborations and licensing
agreements. "This conference is an unrivalled opportunity to meet and
network with the world’s leading pharmaceutical and biotech companies and
the most promising emerging firms developing novel therapeutics at one place
and time," stated Alan Eisenberg, Executive Vice President, Emerging
Companies and Business Development.
The event features private, pre-arranged one-on-one meetings between
senior-level executives and provides a number of ways to explore a range of
exceptional international partnering and licensing opportunities. Over the
course of two days, BIO-Asia will host over 1,500 private meetings and
provide countless formal and informal networking opportunities throughout the
event.
BIO-Asia is a rapidly growing meeting, and in 2006 attracted 400
participants, representing a 33% increase over 2005. These participants
represent more than 200 companies and 22 countries around the world.
Mitsubishi UFJ Securities, Montgomery & Co., and BioCentury Publications are
sponsors and co-hosts of BIO-Asia with support from the Japan Bioindustry
Association (JBA) and the Bioindustry Association of Korea (BAK).
Media registration is complimentary. For more information visit directly
http://www.bio.org/bioasia or contact bioasia@bio.org for assistance.
BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations across
the United States and 31 other nations. BIO members are involved in the
research and development of healthcare, agricultural, industrial and
environmental biotechnology products.
